Dark
Light
System
Institutional Investment Manager
ORBIMED ADVISORS LLC
ORBIMED ADVISORS LLC (CIK: 0001055951) incorporated in Delaware, located at 601 Lexington Avenue, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q4)
Portfolio Summary: 132 holdings with a total value of $7,848,022,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 ALEXION PHARMACEUTIC 3,388,386 414,569,000 5.28%
2 BIOGEN INC 1,281,200 363,323,000 4.63%
3 CELGENE CORP 3,106,777 359,609,000 4.58%
4 BOSTON SCIENTIFIC CORP 16,506,900 357,044,000 4.55%
5 AMGEN INC 2,331,800 340,932,000 4.34%
6 MERCK & CO INC 4,615,200 271,697,000 3.46%
7 INCYTE 2,082,800 208,842,000 2.66%
8 SHIRE PLC 1,203,351 205,027,000 2.61%
9 LILLY ELI & CO 2,739,000 201,453,000 2.57%
10 ABBVIE INC 2,925,000 183,164,000 2.33%
11 Wright Medical Group NV 7,584,334 174,288,000 2.22%
12 HUMANA 836,400 170,651,000 2.17%
13 PFIZER INC 5,167,900 167,853,000 2.14%
14 AGILENT TECHNOLOGIES INC 3,629,900 165,378,000 2.11%
15 ALLERGAN PLC 769,690 161,643,000 2.06%
16 VERTEX PHARMACEUT 2,159,400 159,083,000 2.03%
17 HCA HOLDINGS INC 2,002,200 148,203,000 1.89%
18 ANTHEM INC 1,021,600 146,875,000 1.87%
19 ARRAY BIOPHARMA INC COM 16,088,800 141,421,000 1.80%
20 REGENERON PHARMACEUTICALS 355,300 130,427,000 1.66%
21 EDWARDS LIFESCIENCES CORP 1,351,400 126,626,000 1.61%
22 INTERCEPT PHARMACEUTICAL 1,120,000 121,688,000 1.55%
23 THERMO FISHER SCIENTIFIC INC 799,500 112,809,000 1.44%
24 SYNERGY PHARMACEUTICALS DEL COM NEW 18,241,398 111,090,000 1.42%
25 IRONWOOD PHARMACEUTICALS INC COM CL A 7,241,300 110,719,000 1.41%
26 BIOMARIN 1,274,100 105,546,000 1.34%
27 AETNA INC NEW 805,900 99,940,000 1.27%
28 JOHNSON & JOHNSON 858,000 98,850,000 1.26%
29 INTUITIVE SURGICAL INC 145,500 92,272,000 1.18%
30 Audentes Therapeutics, Inc. 4,801,638 87,726,000 1.12%
31 BRISTOL MYERS SQUIBB CO 1,493,500 87,280,000 1.11%
32 NEUROCRINE BIOSCIE COM USD0.001 2,128,774 82,384,000 1.05%
33 CORVUS PHARMACEUTICALS INC COM 5,379,349 76,925,000 0.98%
34 GILEAD SCIENCES INC 1,055,100 75,556,000 0.96%
35 GLAUKOS CORP 2,180,000 74,774,000 0.95%
36 MALLINCKRODT PUB LTD CO SHS 1,472,700 73,370,000 0.93%
37 INSMED INC COM PAR .01 5,301,805 70,143,000 0.89%
38 PUMA BIOTECHNOLOGY 2,275,825 69,868,000 0.89%
39 ALLERGAN PLC 88,200 67,249,000 0.86% PRN
40 MAGELLAN HEALTH INC COM NEW 801,600 60,320,000 0.77%
41 AERIE PHARMACEUTICALS INC 1,496,000 56,624,000 0.72%
42 INSYS THERAPEUTICS INC NEW COM NEW 6,071,440 55,857,000 0.71%
43 LOXO ONCOLOGY INC COM 1,728,000 55,495,000 0.71%
44 TENET HEALTHCARE CORP 3,716,700 55,156,000 0.70%
45 Ascendis Pharma 2,717,315 54,998,000 0.70%
46 MEDTRONIC PLC 766,600 54,605,000 0.70%
47 ACHILLION PHARMACEUTICALS INC COM 13,107,200 54,133,000 0.69%
48 EAGLE PHARMACEUTICALS INC COM 671,000 53,237,000 0.68%
49 UNITEDHEALTH GROUP INC 296,400 47,436,000 0.60%
50 Momenta Pharmaceuticals Inc 2,951,968 44,427,000 0.57%
Page 1 of 3

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-17-000766, filed 2017.02.14).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.